Acta Scientific Orthopaedics (ISSN: 2581-8635)

Editorial Volume 5 Issue 3

Chemotherapy Treatment and Muscle Performance in Women with Breast Cancer

Vitor Alves Marques1,2*

1Postgraduate Program in Health Sciences, Federal University of Goias, Brazil
2Physical Education and Dance College, Federal University of Goias, Brazil

*Corresponding Author: Vitor Alves Marques, Postgraduate Program in Health Sciences, Federal University of Goias, Brazil.

Received: December 24, 2021; Published: February 01, 2022

Cancer has been considered a public health problem nearly all over the world, especially in developmental countries. In 2020, approximately 2.26 million of new cases of breast cancer were detected, representing 11.7% of all cancer types diagnosed in women [1].


  1. INCA - Instituto Nacional de Câncer - Estimativa 2016. Ministério da Saúde Instituto Nacional de Cancer José Alencar Gomes da Silva 124 (2016).
  2. Makluf ASD., et al. “Avaliação da qualidade de vida em mulheres com câncer da mama”. Revista Brasileira de Cancerologia1 (2006): 49-58.
  3. Cancer-Related Fatigue. National Comprehensive Cancer Network (2014).
  4. Consenso Brasileiro de Fadiga. “Consenso Brasileiro de Fadiga em Cuidados Paliativos”. Revista Brasileira de Cuidados Paliativos2 (2010): 31-33.
  5. Klassen O., et al. “Muscle strength in breast cancer patients receiving different treatment regimes”. Journal of Cachexia, Sarcopenia and Muscle2 (2017): 305-316.
  6. Ruiz JR., et al. “Association between muscular strength and men: prospective cohort study”. BMJ (2008): 1-9.
  7. Noal S., et al. “One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer”. International Journal of Radiation Oncology Biology Physics 3 (2011): 795-803.


Citation: Vitor Alves Marques. “Chemotherapy Treatment and Muscle Performance in Women with Breast Cancer". Acta Scientific Orthopaedics 5.3 (2022): 01.


Copyright: © 2022 Vitor Alves Marques. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate33%
Acceptance to publication20-30 days

Indexed In

News and Events

Contact US